# Zenlabs Ethica (NSE: ZENLABS) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/ZENLABS · Pivot · prices to 21 Oct 2026

With a market capitalisation of ₹22 Cr, it ranks 3547th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Financials sector; its industry is Medical Distribution.

Its return on equity was −22.7% in FY26. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹429 Cr (−14.0% year on year) and net profit −₹20 Cr (−126.5%), on a consolidated basis. Promoters held 52.96% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹22 Cr |
| ROE | −22.7% (FY26) |
| ROCE | 10.7% (FY26) |
| Debt to equity | 1.22 |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹429 Cr | −14.0% | −₹20 Cr | −126.5% | −₹2.16 |
| Q4 FY26 | ₹398 Cr | −23.5% | ₹86 Cr | +805.7% | ₹1.27 |
| Q3 FY26 | ₹406 Cr | −24.1% | ₹9 Cr | −36.8% | ₹0.27 |
| Q2 FY26 | ₹526 Cr | +65.1% | ₹190 Cr | +986.1% | −₹0.84 |
| Q1 FY26 | ₹499 Cr | +99.4% | ₹76 Cr | +211.2% | ₹6.04 |
| Q4 FY25 | ₹520 Cr | +95.4% | ₹10 Cr | +334.7% | ₹0.22 |
| Q3 FY25 | ₹535 Cr | +66.9% | ₹14 Cr | −52.5% | ₹3.84 |
| Q2 FY25 | ₹319 Cr | +7.3% | ₹17 Cr | −27.8% | ₹3.11 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹51 Cr | ₹0 Cr |
| FY24 | ₹59 Cr | ₹0 Cr |
| FY23 | ₹67 Cr | ₹0 Cr |
| FY22 | ₹69 Cr | ₹1 Cr |
| FY21 | ₹57 Cr | ₹1 Cr |
| FY20 | ₹60 Cr | −₹1 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 52.96%
- Non-institutions: 47.04%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Adcon Capital](https://app.pivotnow.in/stock/ADCON) | — | ₹22 Cr | — | — |
| [Helpage Fin](https://app.pivotnow.in/stock/HELPAGE) | — | ₹22 Cr | — | — |
| [KJMC Corporate](https://app.pivotnow.in/stock/KJMCCORP) | — | ₹22 Cr | — | — |
| [Navigant Corp.](https://app.pivotnow.in/stock/NAVIGANT) | — | ₹22 Cr | — | — |
| [Shricon Ind](https://app.pivotnow.in/stock/SHRICON) | — | ₹22 Cr | — | — |
| [TTI Enterprise](https://app.pivotnow.in/stock/TTIENT) | — | ₹22 Cr | — | — |

## Questions and answers

### What is the market cap of Zenlabs Ethica?

Zenlabs Ethica's market capitalisation is ₹22 Cr (₹22 Cr) at the 21 Oct 2026 close, ranking 3547th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Zenlabs Ethica?

Return on equity was −22.7% in FY26 and return on capital employed was 10.7% in FY26 (standalone figures).

### What were Zenlabs Ethica's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Zenlabs Ethica reported revenue of ₹429 Cr, −14.0% year on year, and net profit of −₹20 Cr, −126.5% year on year.

### What is the shareholding pattern of Zenlabs Ethica?

As of 30 Jun 2026: promoters 52.96%, non-institutions 47.04%.

### Who are Zenlabs Ethica's competitors?

The listed Financials companies closest to Zenlabs Ethica by market cap are Adcon Capital, Helpage Fin, KJMC Corporate, Navigant Corp., Shricon Ind and TTI Enterprise.

### Is Zenlabs Ethica a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Zenlabs Ethica's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ZENLABS against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.